Literature DB >> 10978751

Modification of surface histidine residues abolishes the cytotoxic activity of Clostridium difficile toxin A.

A K Roberts1, C C Shone.   

Abstract

Clostridium difficile toxin A displays both cytotoxic and enterotoxic activities. It has recently been demonstrated that toxin A exerts its cytotoxic effect by the glucosylation of the small GTP-binding proteins of the Rho family. Diethyl pyrocarbonate, at pH 7.0, was used to chemically modify exposed histidine residues on toxin A. Modification of toxin A with diethyl pyrocarbonate abolished both its cytotoxic activity and the ability of the toxin to bind Zn-Sepharose gel. Treatment of toxin A with [(14)C]-diethyl pyrocarbonate revealed concentration dependent labelling of histidine residues on the toxin molecules. The effects of diethyl pyrocarbonate could be reversed by hydroxylamine treatment. These data suggest the modified histidine residues on toxin A are critical to its cytotoxic activity. Histidine modification had no effect on the glucosyl transferase enzyme activity of toxin A. However, modification abolished the 'cold' binding of toxin to bovine thyroglobulin in an ELISA and reduced ligand binding activity in a rabbit erythrocyte haemagglutination assay. The data suggest that the histidine residues may be crucial to the receptor-binding activity of toxin A. Exposed histidines on toxin A are available for zinc chelation, and these have been exploited in the development of a novel purification protocol for toxin A using zinc-chelating chromatography.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 10978751     DOI: 10.1016/s0041-0101(00)00132-x

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  4 in total

1.  Development and evaluation of an ovine antibody-based platform for treatment of Clostridium difficile infection.

Authors:  April Roberts; Joanna McGlashan; Ibrahim Al-Abdulla; Roger Ling; Harriet Denton; Steve Green; Ruth Coxon; John Landon; Clifford Shone
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Functional significance of active site residues in the enzymatic component of the Clostridium difficile binary toxin.

Authors:  Abigail H Davies; Joanna McGlashan; Mareike G Posner; April K Roberts; Clifford C Shone; K Ravi Acharya
Journal:  Biochem Biophys Rep       Date:  2016-08-11

3.  Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.

Authors:  Michael Maynard-Smith; Helen Ahern; Joanna McGlashan; Philip Nugent; Roger Ling; Harriet Denton; Ruth Coxon; John Landon; April Roberts; Clifford Shone
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

4.  High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection.

Authors:  Tanya M Monaghan; Ola H Negm; Brendon MacKenzie; Mohamed R Hamed; Clifford C Shone; David P Humphreys; K Ravi Acharya; Mark H Wilcox
Journal:  Clin Exp Gastroenterol       Date:  2017-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.